A recent meta-analysis involving 9 studies with 806 GBM patients demonstrated a significant association between PD-L1 expression in tumor tissues and reduced overall survival, as well as a trend linking PD-L1 expression to the IDH1 gene mutation status. The gene discussed is CD274; the disease is neoplasm.